Evidence map›Paper›PMID 40930304›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2026

Fecal Microbiota-Based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C difficile Infection.

Larry Nguyen, Paul Feuerstadt, Jessica R Allegretti, Jordan Axelrad

Abstract readComparative StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Larry NguyenNYU Grossman School of Medicine, Department of Medicine, New York, New York. Electronic address: larry.nguyenmd@gmail.com.
Paul FeuerstadtYale School of Medicine, Attending Gastroenterologist, PACT Gastroenterology Center, Hamden, Connecticut.
Jessica R AllegrettiBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Jordan AxelradInflammatory Bowel Disease Center at NYU Langone Health, New York, New York.

Funding

The Role of Enteric Infection in Flares of Inflammatory Bowel DiseaseK23DK124570 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AXELRAD, JORDAN ERIC · 2021 to 2025
$998k
NIDDK NIH HHS K23 DK124570
6 · The paper itself

Abstract

Fecal microbiota-based therapies are safe and effective in preventing recurrent Clostridioides difficile infection (rCDI) after standard of care (SOC) antibiotic treatment with either vancomycin or fidaxomicin.

Indexed as

Clostridium InfectionsFecal Microbiota TransplantationSecondary PreventionAnti-Bacterial AgentsClostridioides difficileFecesFemaleGastrointestinal MicrobiomeHumansMaleRecurrenceTreatment OutcomeAnti-Bacterial Agents

Identifiers

PMID40930304
PMCPMC12433683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.